Aberrant receptor signaling and trafficking as mechanisms in oncogenesis

Kaisa Haglund1, Tor Erik Rusten, Harald Stenmark

  • 1Centre for Cancer Biomedicine, University of Oslo, and Department of Biochemistry, Institute for Cancer Research, the Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.

Insights

Cell surface receptor signaling pathways are crucial for normal cell functions. Their dysregulation in cancer, involving pathways like WNT and Notch, drives oncogenesis, with endocytic trafficking playing a key role.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Cell surface receptor signaling pathways regulate fundamental cellular processes like proliferation, differentiation, survival, and migration.
  • Aberrant signaling, driven by genetic or epigenetic alterations, is a critical mechanism in cancer development (oncogenesis).

Purpose of the Study:

  • To review key cell surface receptor signaling pathways dysregulated in cancer, including receptor tyrosine kinases, WNT, TGF-beta, and Notch.
  • To elucidate the contribution of these pathway dysfunctions to oncogenesis.
  • To highlight the role of endocytic membrane trafficking in both receptor signaling and tumor suppression.

Main Methods:

  • Literature review of prominent receptor signaling pathways in cancer.
  • Analysis of mechanisms linking pathway dysfunction to oncogenesis.
  • Examination of the role of endocytic trafficking in receptor signaling and tumor suppression.

Main Results:

  • Dysregulation of receptor tyrosine kinases, WNT, TGF-beta, and Notch signaling pathways is frequently observed in various cancers.
  • These dysregulated pathways promote uncontrolled cell growth, survival, and metastasis, key hallmarks of cancer.
  • Endocytic membrane trafficking is integral to the regulation of receptor signaling and functions as a tumor suppressor mechanism.

Conclusions:

  • Understanding the specific roles of dysregulated signaling pathways and endocytic trafficking is crucial for developing targeted cancer therapies.
  • Targeting these pathways offers potential therapeutic strategies for oncogenesis.
  • Further research into the interplay between receptor signaling and endocytic trafficking may reveal novel avenues for cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...